• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液肿瘤患者过滤血细胞置换后的抗体形成]

[Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].

作者信息

Barz D, Staack D, Lehmann R, Stange K, Schnurstein K

机构信息

Abteilung Transfusionsmedizin, Universität Rostock, Deutschland.

出版信息

Beitr Infusionsther Transfusionsmed. 1996;33:30-4.

PMID:8974705
Abstract

We studied the value of leucocyte depletion of platelet and erythrocyte transfusion by filter for the prevention of alloimmunization. In 109 patients with hematological diseases we detected HLA- and platelet specific antibodies by using lymphocytotoxic and IgG-EIA-Thrombomatch. In 17 of the 109 evaluable patients (16%) HLA-antibodies developed (9 female and 8 male). 16 of the 17 had only HLA-antibodies and 1 patient a platelet specific alloantibody primary immunisation. 15 of 17 with a high-risk of prior immunization induced by pregnancy or other transfusions had a 'secondary alloimmunization'.

摘要

我们研究了通过滤器去除血小板和红细胞输血中的白细胞对预防同种免疫的价值。在109例血液病患者中,我们采用淋巴细胞毒试验和IgG - EIA - 血栓配型检测HLA和血小板特异性抗体。在109例可评估患者中,有17例(16%)产生了HLA抗体(9例女性和8例男性)。这17例中的16例仅产生了HLA抗体,1例患者初次免疫产生了血小板特异性同种抗体。17例中有15例因妊娠或其他输血有既往免疫高风险,发生了“继发性同种免疫”。

相似文献

1
[Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].[血液肿瘤患者过滤血细胞置换后的抗体形成]
Beitr Infusionsther Transfusionsmed. 1996;33:30-4.
2
[Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
Beitr Infusionsther Transfusionsmed. 1996;33:47-54.
3
[Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
Beitr Infusionsther. 1990;26:153-6.
4
[Prevention of HLA antibody formation in patients with hemato-oncologic diseases by using leukocyte depleted blood preparations].[通过使用去除白细胞的血液制品预防血液肿瘤疾病患者 HLA 抗体形成]
Infusionsther Transfusionsmed. 1995 Feb;22(1):9-13.
5
[Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].[白细胞去除血小板浓缩物预防频繁输血患者 HLA 同种免疫的疗效:一项使用聚酯血小板滤器的前瞻性多机构研究]
Rinsho Ketsueki. 1992 Apr;33(4):451-60.
6
[Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].[多次输血治疗的肿瘤血液疾病患者的血小板同种免疫:成人和儿童的前瞻性研究]
Rev Med Chil. 1997 Nov;125(11):1305-12.
7
[Prevention of HLA-alloimmunization of recipients of platelet concentrates].[预防血小板浓缩物接受者的HLA同种免疫]
Beitr Infusionsther. 1991;28:209-12.
8
[Development of HLA antibodies in thrombocyte substitution with cell separator products].[使用细胞分离器产品进行血小板替代时HLA抗体的产生]
Beitr Infusionsther. 1992;30:416-9.
9
Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.血液肿瘤疾病多次输血患者的血小板同种免疫
Natl Med J India. 2005 May-Jun;18(3):134-6.
10
Sensitization by platelet transfusion.血小板输注致敏
Schweiz Med Wochenschr. 1991 Mar 30;121(13):467-9.